NutriDex

The Supplement Research Compendium
💊

Pantethine

Vitamin B5 derivative that modestly lowers cholesterol and triglycerides.

Moderate evidence 🫀Heart & Metabolic

✚ Updated · How we grade evidence

Evidence tier
Moderate
Research weight
Citations
8 verified / 8
Classification
Heart & Metabolic
❝
What the evidence says. Graded moderate: a 16-week placebo-controlled RCT and older double-blind trials show real but small lipid changes (LDL down ~11%), yet most supporting data are uncontrolled, short, industry-linked, and predate modern statins — no outcome (heart-attack) trials exist. (Moderate evidence: Several controlled trials; effects real but modest or context-dependent.)

What is Pantethine?

Pantethine is a heart and metabolic supplement used for lower ldl cholesterol. NutriDex grades the human evidence as Moderate. Pantethine is a stable disulphide form of pantetheine, an active derivative of vitamin B5 (pantothenic acid), marketed to lower blood lipids. In a 16-week, triple-blinded, diet-controlled RCT of low-to-moderate-risk adults, pantethine (600–900 mg/day) reduced LDL cholesterol about 11%, total cholesterol about 6% and non-HDL cholesterol about 8% versus placebo. Older Italian double-blind trials in hyperlipoproteinemia reported total/LDL cholesterol drops near 13% and triglyceride reductions around 30%, and a 2015 multicentre trial found triglycerides fell ~17%. A pooled review of 28 studies (n=646) estimated 12–15% cholesterol reductions over 4 months but mixed uncontrolled trials and was judged methodologically weak. Effects are modest, slower than statins, and no trial has measured heart attacks or deaths. It is best viewed as a gentle diet adjunct for borderline lipids, not a statin substitute.

Purported Benefits

✓Lower LDL cholesterol
✓Lower total cholesterol
✓Lower triglycerides
✓Mild HDL increase
✓Adjunct to diet in mild dyslipidemia

Evidence by outcome

The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.

OutcomeEvidenceEffectStudies
Lower LDL cholesterolTwo triple-blind diet-controlled RCTs show ~11% LDL drop; modest, slower than statins, no hard-outcome data. Moderate ↑ benefit · small 2
Lower total cholesterolRCTs show ~6-13% total-cholesterol reduction; older Italian trials larger but methodology weaker. Moderate ↑ benefit · small 3
Lower triglyceridesTrials report ~16-30% triglyceride reductions, but the larger modern trial showed less effect than a comparator arm. Moderate ↑ benefit · moderate 3
Raise HDL cholesterolOnly an older double-blind trial reported ~10% HDL rise; not consistently confirmed in modern RCTs. Preliminary ↑ benefit · small 1

Dosing & Compounds

Typical Dose
600–900 mg/day, usually split into 2–3 doses with meals; effects build over 8–16 weeks.
Active Compounds
Pantethine (disulphide of pantetheine)Cysteamine (active metabolite)

Safety & Cautions

Generally well tolerated: in pooled data only ~3.6% reported side effects (mainly heartburn, epigastric discomfort, nausea, diarrhoea or itching) and dropout was under 2%. Because it lowers lipids and may affect platelet function, theoretical additive effects exist with statins, fibrates and antiplatelet/anticoagulant drugs (e.g. aspirin, warfarin) — monitor if combined. Long-term and pregnancy safety are not well studied, and it should not replace prescribed lipid therapy; tell your doctor before adding it. Educational only — always check with your doctor or pharmacist before combining Pantethine with any medicine.

Key Studies

Systematic review McRae 2005 ✓ Full text
Pooled review of 28 studies (n=646): mean total cholesterol −8.7% to −15.1% and triglycerides −14% to −33% over 1–4 months.
RCT Bo 2015 ✓ PubMed
Randomized double-blind multicentre trial (n=216): pantethine 600 U/day lowered triglycerides 16–17% vs baseline (less than coenzyme A arm).
RCT Evans 2014 ✓ PubMed
16-wk triple-blind RCT (n=32): pantethine cut LDL-C ~11% (P=0.006), total cholesterol ~6% and non-HDL ~8% vs placebo.
RCT Rumberger 2011 ✓ PubMed
Triple-blind diet-controlled RCT (n=120): LDL-C fell ~11% from baseline on pantethine 600–900 mg/day; +3% on placebo at week 16.
RCT Gaddi 1984 ✓ PubMed
Double-blind trial in hyperlipoproteinemia (n=29): type IIB total/LDL cholesterol −13.5%, triglycerides ~−30%, HDL +~10%.
RCT Gaddi 1984 (diabetes) ✓ PubMed
Treatment of 37 hyperlipidemic patients (21 diabetic): progressive falls in cholesterol, triglycerides, LDL and apoB; HDL and apoA rose.
RCT Prisco 1987 ✓ PubMed
Pantethine lowered plasma beta-thromboglobulin and lipids in diabetes mellitus, suggesting effects on platelet activity alongside lipids.
Cohort Donati 1989 ✓ PubMed
Postmarketing surveillance of 1045 hyperlipidemic patients (incl. 298 diabetics): significant lipid improvements with good tolerability.
8 sources cited · 8 verified Search all studies on PubMed ↗

Common questions about Pantethine

What is Pantethine used for?

Pantethine is most often taken for Lower LDL cholesterol, Lower total cholesterol, Lower triglycerides, Mild HDL increase. Vitamin B5 derivative that modestly lowers cholesterol and triglycerides.

Does Pantethine work — what does the evidence say?

Moderate evidence. Several controlled trials; effects real but modest or context-dependent. Pantethine is a stable disulphide form of pantetheine, an active derivative of vitamin B5 (pantothenic acid), marketed to lower blood lipids. In a 16-week, triple-blinded, diet-controlled RCT of low-to-moderate-risk adults, pantethine (600–900 mg/day) reduced LDL cholesterol about 11%, total cholesterol about 6% and non-HDL cholesterol about 8% versus placebo. Older Italian double-blind trials in hyperlipoproteinemia reported total/LDL cholesterol drops near 13% and triglyceride reductions around 30%, and a 2015 multicentre trial found triglycerides fell ~17%. A pooled review of 28 studies (n=646) estimated 12–15% cholesterol reductions over 4 months but mixed uncontrolled trials and was judged methodologically weak. Effects are modest, slower than statins, and no trial has measured heart attacks or deaths. It is best viewed as a gentle diet adjunct for borderline lipids, not a statin substitute.

What is the typical dose of Pantethine?

600–900 mg/day, usually split into 2–3 doses with meals; effects build over 8–16 weeks.

Is Pantethine safe? Any cautions or side effects?

Generally well tolerated: in pooled data only ~3.6% reported side effects (mainly heartburn, epigastric discomfort, nausea, diarrhoea or itching) and dropout was under 2%. Because it lowers lipids and may affect platelet function, theoretical additive effects exist with statins, fibrates and antiplatelet/anticoagulant drugs (e.g. aspirin, warfarin) — monitor if combined. Long-term and pregnancy safety are not well studied, and it should not replace prescribed lipid therapy; tell your doctor before adding it.

How many studies support Pantethine?

NutriDex cites 8 sources for Pantethine, graded "Moderate".

Cite this page
APA

Peh, D. (2026). Pantethine: Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 26 Jun 2026, from https://nutridex.info/s/pantethine

BibTeX
@misc{nutridex_pantethine,
  author       = {Peh, Daryl},
  title        = {Pantethine: Benefits, Dosage, Side Effects \& Evidence},
  year         = {2026},
  howpublished = {NutriDex --- The Supplement Research Compendium},
  url          = {https://nutridex.info/s/pantethine},
  note         = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-06-26}
}

For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.

← Back to the full dex · All substances